Leidos subcontracts malaria vaccine work to Pfenex; GSK nears expanded label for pneumococcal vaccine;

> Leidos has subcontracted part of its NIH malaria vaccine contract to Pfenex. Release

> GlaxoSmithKline ($GSK) is one step closer to expanding the European label for its pneumococcal conjugate vaccine. Item

> Researchers are developing a diagnostic chip to predict whether a vaccine will provide protection. Abstract

> Vietnam is still investigating why three newborns died after receiving hepatitis B vaccines. Article

> Chinese scientists are aiming to introduce a H7N9 vaccine within 6 months. Piece

> Cuba is developing two oral cholera vaccines, one of which is in advanced clinical trials. Post

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

Find out how PDA can help you succeed with custom solutions and training for your employees – at your facility, our facility, or virtually.

Iowa State University is working on a room-temp-stable nasal spray vaccine for COVID-19, and it recently tapped device maker Zeteo for support.

Pfizer's shot will go before an FDA expert panel on Dec. 10, with Moderna's review pegged for the 17th, Warp Speed chief Moncef Slaoui, Ph.D., said.